Parkinsonics: A Controlled Study of Group Singing in Parkinson Disease Trial Phase 2 Completed Feb. 28, 2017
Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease Trial Phase 2 Completed Feb. 22, 2017
Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's Disease Trial Phase 3 Completed Feb. 22, 2017
Piloting a Novel, Mobile Cognitive Tracking and Training Tool for Patients With Parkinson's Disease (PD) Trial N/A Withdrawn Feb. 22, 2017
Motor Control During Rapid Eye Movement (REM) Sleep Behaviour Disorder Trial N/A Terminated Feb. 22, 2017
Transcutaneous Electric Nerve Stimulation in Sleep of Patients With Parkinson's Disease Trial N/A Completed Feb. 14, 2017
Expiratory Muscle Training for Persons With Neurodegenerative Disease Trial Phase 2 Completed Feb. 9, 2017
A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders Trial Phase 2 Completed Feb. 8, 2017
Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) Trial Phase 2 Withdrawn Feb. 6, 2017
Computerized Cognitive Behavioral Therapy Trial for Insomnia in Parkinson Disease Trial N/A Completed Feb. 1, 2017
Subthalamotomy by ExAblate Transcranial System to Treat Motor Features of Parkinson's Disease Trial N/A Completed Jan. 30, 2017
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder) Trial Phase 1 Completed Jan. 29, 2017
Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease Trial Phase 4 Completed Jan. 29, 2017
Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes Trial N/A Completed Jan. 26, 2017